Skip to main content
CGTX logo

CGTX · Cognition Therapeutics Inc

Track CGTX — free
$1.01 -0.03 (-2.88%) At close · Aug 14
Market Cap
$96.04M
Shares
95.09M

Cognition Therapeutics Inc Earnings Call Transcripts

Every quarterly earnings call for Cognition Therapeutics Inc (CGTX) — the full transcript with speaker labels, the audio replay, AI call highlights and a management-tone score, plus the matching 8-K earnings release and the quarter's 10-Q or 10-K. Investor days and conferences appear here too.

Conference
Investor event
2026-06-04
Jefferies Global Healthcare Conference
No reported result — non-financial event
Audio Transcript Slides
Conference
Investor event
2026-04-13
25th Annual Needham Virtual Healthcare Conference
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY25 · Q4
2026-03-26
Cognition Therapeutics Inc Q4 FY2025 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY25 · Q2
2025-08-07
Cognition Therapeutics Inc Q2 FY2025 Earnings Call
Diluted EPS
$-0.11
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q1
2025-05-07
Cognition Therapeutics Inc Q1 FY2025 Earnings Call
Diluted EPS
$-0.14
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q4
2025-03-20
Cognition Therapeutics Inc Q4 FY2024 Earnings Call
Positive tone Alzheimer's Disease Program with Zervimesine Dementia with Lewy Bodies (DLB) Program Funding, Partnerships and Capital Needs
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY24 · Q2
2024-08-08
Cognition Therapeutics Inc Q2 FY2024 Earnings Call
Diluted EPS
$-0.18
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q1
2024-05-07
Cognition Therapeutics Inc Q1 FY2024 Earnings Call
Positive tone SHINE trial results SHIMMER trial in dementia with Lewy bodies Biomarker and mechanism evidence
Diluted EPS
$-0.27
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q4
2024-03-26
Cognition Therapeutics Inc Q4 FY2023 Earnings Call
Confident tone SHINE Phase 2 Alzheimer's trial readout START early Alzheimer's trial with ACTC MAGNIFY geographic atrophy / dry AMD trial
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY23 · Q2
2023-08-08
Cognition Therapeutics Inc Q2 FY2023 Earnings Call
Diluted EPS
$-0.16
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q4
2023-03-23
Cognition Therapeutics Inc Q4 FY2022 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY21 · Q4
2022-03-30
Cognition Therapeutics Inc Q4 FY2021 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-K
Showing 1–12 of 12 earnings calls
Key facts CIK 1455365 CUSIP 19243B102 13F (30d) 60 filings 60 filers Visit website Investor relations